IP Library Granted Patent US 7,691,835
Granted Patent B2
US 7,691,835 · App. 11/835,367 · Granted Apr 6, 2010

Formulations

Assignee: Hollis-Eden Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,691,835
App. No.
11/835,367
Granted
Apr 6, 2010
Kind
B2
Abstract

The invention provides methods to treating conditions such as prostate cancer, or for ameliorating one or more symptoms associated with prostate cancer, or for agents that modulate the biological activity of the androgen receptor. The invention also provides methods and compositions suitable for therapeutic applications.

Claims (6)

1. A method to treat a condition selected from the group consisting of benign prostatic hyperplasia, prostate cancer and breast cancer in a mammal in need thereof comprising administering to the mammal an effective amount of a group 8 compound having the structure

2. The method of claim 1 wherein the compound has the structure

3. The method of claim 2 wherein the mammal is a human.

4. The method of claim 3 wherein the condition is benign prostatic hyperplasia.

5. The method of claim 3 wherein the condition is prostate cancer.

6. The method of claim 3 wherein the condition is breast cancer.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2021
From: NEURMEDIX, INC.
To: NEURMEDIX, LLC
Reel/Frame 057116/0336 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2021
From: NEURMEDIX, LLC
To: NEURMEDIX, INC.
Reel/Frame 057116/0362 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2021
From: NEURMEDIX, INC.
To: BIOVIE INC.
Reel/Frame 057116/0451 →
CHANGE OF NAME Recorded Nov 2, 2012
From: HARBOR BIOSCIENCES, INC.
To: HARBOR DIVERSIFIED, INC.
Reel/Frame 029227/0929 →
CHANGE OF NAME Recorded Mar 3, 2010
From: HOLLIS-EDEN PHARMACEUTICALS, INC.
To: HARBOR BIOSCIENCES, INC.
Reel/Frame 024024/0294 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2007
From: FRINCKE, JAMES M; LARDY, HENRY; MARWAH, PADMA
To: HOLLIS-EDEN PHARMACEUTICALS, INC.
Reel/Frame 019681/0090 →
Continuity (5)
Continuation 0967532300 · Sep 28, 2000
Provisional Application 6015727500 · Sep 30, 1999
Provisional Application 6015734700 · Sep 30, 1999
Provisional Application 6016611600 · Nov 16, 1999
Related Publication 20080058301A1 · Mar 6, 2008